Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Business Wire•15/10/2026•07:00 ET
0
Key Highlights
- ➤Rocket Pharmaceuticals (RCKT) will participate in Chardan’s 10th Annual Healthcare Conference.
- ➤Rocket will join a panel October 20, 2026, at 11:30 AM ET.
- ➤Rocket will host investor meetings during the conference.
- ➤Rocket’s cardiovascular portfolio includes three clinical-stage gene therapy programs.
Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that the company will attend Chardan’s 10th Annual Healthcare Conference. The company will participate in a panel on Tuesday, October 20, 2026, at 11:30 AM ET and host investor meetings.
Get started
Create a free account to read the full story.